SCHEMBL24993543

SCHEMBL24993543

CCOc1ccc(-c2cnc(Cl)c(C(=O)OC)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.52
▸ RAB9A P51151 4/20 0.52
▸ MAPT P10636 5/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ SCN2A Q99250 3/20 0.47
▸ SCN10A Q9Y5Y9 3/20 0.47
▸ ADORA3 P0DMS8 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ ALDH1A1 P00352 5/20 0.43
▸ CHRNA7 P36544 1/20 0.43
▸ HPGD P15428 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ ALPL P05186 2/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PRKDC P78527 1/20 0.41
▸ ATR Q13535 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24993600 0.86 NPC1 (0.53) NPC1RAB9AMAPTKDM4ESCN2A
SCHEMBL24994337 0.85 NPC1 (0.52) NPC1RAB9AMAPTKDM4ESCN2A
SCHEMBL24994737 0.85 NPC1 (0.52) NPC1RAB9AMAPTKDM4ESCN2A
SCHEMBL3461782 0.82 IKBKB (0.48) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL24993550 0.81 NPC1 (0.52) NPC1RAB9AMAPTKDM4ESCN2A
SCHEMBL24993576 0.80 NPC1 (0.50) NPC1RAB9AMAPTKDM4ESCN2A
SCHEMBL24994722 0.77 NPC1 (0.46) NPC1RAB9AMAPTKDM4ESCN2A
SCHEMBL24994319 0.76 SCN10A (0.64) NPC1RAB9AMAPTKDM4ESCN2A
SCHEMBL22595056 0.76 NPC1 (0.57) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL31547771 0.75 RAB9A (0.57) NPC1RAB9AKDM4EADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382100-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
CN-118076348-A N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods of making, compositions, uses, methods of treatment and kits using the same 欧罗法玛实验室股份公司 2024-05-24 — — CN disclosed
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback